Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jul;78(2):221–224. doi: 10.1038/bjc.1998.468

Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

T Takano 1, F Matsuzuka 1, A Miyauchi 1, T Yokozawa 1, G Liu 1, S Morita 1, K Kuma 1, N Amino 1
PMCID: PMC2062902  PMID: 9683297

Abstract

Restricted expression of oncofetal fibronectin mRNA in the tissues of thyroid papillary and anaplastic carcinoma has recently been shown by both Northern blot analysis and reverse transcriptase polymerase chain reaction (RT-PCR). Oncofetal fibronectin mRNA can be a target of gene diagnosis and targeted gene therapy, provided it is expressed in all cancer cells in the tissues. To investigate this criterion in thyroid cancer tissues, we measured their expression of oncofetal fibronectin mRNA using in situ hybridization. An abundant expression of oncofetal fibronectin mRNA was found in all the observed cancer cells of six papillary carcinomas and an anaplastic carcinoma, but not in the tissues of normal thyroid, Graves' disease, adenomatous goitre, follicular adenoma, follicular carcinoma or medullary carcinoma. This result encourages us to establish gene diagnosis of thyroid papillary and anaplastic carcinomas by detecting oncofetal fibronectin mRNA in biopsies.

Full text

PDF
223

Images in this article

223Figure 1
on p.223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. David L., Mandel U., Clausen H., Sobrinho-Simões M. Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach. Eur J Cancer. 1993;29A(14):2070–2071. doi: 10.1016/0959-8049(93)90476-v. [DOI] [PubMed] [Google Scholar]
  2. Hedinger C., Williams E. D., Sobin L. H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989 Mar 1;63(5):908–911. doi: 10.1002/1097-0142(19890301)63:5<908::aid-cncr2820630520>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  3. Hirota S., Ito A., Morii E., Wanaka A., Tohyama M., Kitamura Y., Nomura S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization histochemistry. Brain Res Mol Brain Res. 1992 Sep;15(1-2):47–54. doi: 10.1016/0169-328x(92)90150-a. [DOI] [PubMed] [Google Scholar]
  4. Inufusa H., Nakamura M., Adachi T., Nakatani Y., Shindo K., Yasutomi M., Matsuura H. Localization of oncofetal and normal fibronectin in colorectal cancer. Correlation with histologic grade, liver metastasis, and prognosis. Cancer. 1995 Jun 15;75(12):2802–2808. doi: 10.1002/1097-0142(19950615)75:12<2802::aid-cncr2820751204>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Katoh R., Bray C. E., Suzuki K., Komiyama A., Hemmi A., Kawaoi A., Oyama T., Sugai T., Sasou S. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol. 1995 Feb;26(2):139–146. doi: 10.1016/0046-8177(95)90029-2. [DOI] [PubMed] [Google Scholar]
  6. Kornblihtt A. R., Umezawa K., Vibe-Pedersen K., Baralle F. E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 1985 Jul;4(7):1755–1759. doi: 10.1002/j.1460-2075.1985.tb03847.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Loridon-Rosa B., Vielh P., Matsuura H., Clausen H., Cuadrado C., Burtin P. Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections. Cancer Res. 1990 Mar 1;50(5):1608–1612. [PubMed] [Google Scholar]
  8. Matsuura H., Hakomori S. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6517–6521. doi: 10.1073/pnas.82.19.6517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Takano T., Matsuzuka F., Sumizaki H., Kuma K., Amino N. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res. 1997 Sep 1;57(17):3792–3797. [PubMed] [Google Scholar]
  10. Takano T., Sumizaki H., Amino N. Detection of CD44 variants in fine needle aspiration biopsies of thyroid tumor by RT-PCR. J Exp Clin Cancer Res. 1997 Sep;16(3):267–271. [PubMed] [Google Scholar]
  11. Tielens E. T., Sherman S. I., Hruban R. H., Ladenson P. W. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994 Jan 15;73(2):424–431. doi: 10.1002/1097-0142(19940115)73:2<424::aid-cncr2820730230>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  12. Yamada K. M., Weston J. A. Isolation of a major cell surface glycoprotein from fibroblasts. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3492–3496. doi: 10.1073/pnas.71.9.3492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES